Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology
Sign Up to like & getrecommendations! Published in 2022 at "Nature Communications"
DOI: 10.1038/s41467-022-28496-1
Abstract: Metabolic alterations precede cardiometabolic disease onset. Here we present ceramide- and dihydroceramide-profiling data from a nested case-cohort (type 2 diabetes [T2D, n = 775]; cardiovascular disease [CVD, n = 551]; random subcohort [ n = 1137]) in the… read more here.
Keywords: risk; cardiometabolic disease; dihydroceramide ceramide; t2d ... See more keywords